These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8381884)

  • 1. [Recombinant Oka varicella vaccine as a live hepatitis B virus vaccine].
    Shiraki K; Takahara T
    Nihon Rinsho; 1993 Jan; 51(1):241-7. PubMed ID: 8381884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of immunogenic recombinant Oka varicella vaccine expressing hepatitis B virus surface antigen.
    Shiraki K; Hayakawa Y; Mori H; Namazue J; Takamizawa A; Yoshida I; Yamanishi K; Takahashi M
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1393-9. PubMed ID: 1646279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Processing of hepatitis B virus surface antigen expressed by recombinant Oka varicella vaccine virus.
    Shiraki K; Ochiai H; Matsui S; Aiba N; Yoshida Y; Okuno T; Yamanishi K; Takahashi M
    J Gen Virol; 1992 Jun; 73 ( Pt 6)():1401-7. PubMed ID: 1318942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
    Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
    Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel immunogenicity of Oka varicella vaccine vector expressing hepatitis B surface antigen.
    Kamiyama T; Sato H; Takahara T; Kageyama S; Shiraki K
    J Infect Dis; 2000 Mar; 181(3):1158-61. PubMed ID: 10720546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed-type hypersensitivity and in vitro lymphocyte response in guinea pigs immunized with a live varicella vaccine.
    Shiraki K; Yamanishi K; Takahashi M; Dohi Y
    Biken J; 1984 Mar; 27(1):19-22. PubMed ID: 6091616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
    Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
    Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer.
    Akbar SM; Furukawa S; Hasebe A; Horiike N; Michitaka K; Onji M
    Int J Mol Med; 2004 Aug; 14(2):295-9. PubMed ID: 15254781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of Oka varicella vaccine expressing human immunodeficiency virus env antigen.
    Shiraki K; Sato H; Yoshida Y; Yamamura JI; Tsurita M; Kurokawa M; Kageyama S
    J Med Virol; 2001 Jun; 64(2):89-95. PubMed ID: 11360239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
    Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
    HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Construction of recombinant adeno-associated virus carrying hepatitis B surface antigen gene and preliminary study of the gene expression and function].
    Hu GF; Wu XB; Yu SY; Dong XY; Chen Q; Hou YD
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Jun; 23(6):553-6. PubMed ID: 12810373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of humoral and cell-mediated immunity to hepatitis B surface antigen by a novel adjuvant activity of Oka varicella vaccine.
    Phumiamorn S; Sato H; Kamiyama T; Kurokawa M; Shiraki K
    J Gen Virol; 2003 Feb; 84(Pt 2):287-291. PubMed ID: 12560559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel hepatitis B virus variant S 129 (Gln-->Leu): lack of correlation between antigenicity and immunogenicity.
    Wu L; He JW; Yao X; Li HM; Wen YM
    J Med Virol; 1999 Dec; 59(4):424-30. PubMed ID: 10534722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.
    Shimizu Y; Guidotti LG; Fowler P; Chisari FV
    J Immunol; 1998 Nov; 161(9):4520-9. PubMed ID: 9794377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
    Zhou C; Peng G; Jin X; Tang J; Chen Z
    Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimisation of secretion of recombinant HBsAg virus-like particles: Impact on the development of HIV-1/HBV bivalent vaccines.
    Michel M; Lone YC; Centlivre M; Roux P; Wain-Hobson S; Sala M
    Vaccine; 2007 Feb; 25(10):1901-11. PubMed ID: 17005303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression, purification and characterization of the Hepatitis B virus entire envelope large protein in Pichia pastoris.
    Han X; Ye LB; Li BZ; Bo G; Cai WJ; Hong Z; She YL; Li Y; Kong LB; Wu ZH
    Protein Expr Purif; 2006 Oct; 49(2):168-75. PubMed ID: 16829133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of a live varicella vaccine (Oka strain).
    Takahashi M
    Biken J; 1984 Sep; 27(2-3):31-6. PubMed ID: 6100054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage.
    Meola A; Delmastro P; Monaci P; Luzzago A; Nicosia A; Felici F; Cortese R; Galfrè G
    J Immunol; 1995 Apr; 154(7):3162-72. PubMed ID: 7534789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
    Li X; Yang X; Li L; Liu H; Liu J
    Vaccine; 2006 Apr; 24(16):3321-31. PubMed ID: 16472546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.